This short video briefly touches on Angie's story after her diagnosis and how MammaPrint helped guide her and her physician with her treatment management plan.
Go to [ Ссылка ] or KnowYourBreastCancer.com for more information.
MammaPrint® FFPE is a FDA-cleared in vitro diagnostic test, performed in a central laboratory, using the gene expression profile obtained from formalin-fixed paraffin embedded (FFPE) breast cancer tissue samples to assess a patient’s risk for distant metastasis within 5 years. The test is performed for breast cancer patients, with Stage I or Stage II disease, with tumor size ≤ 5.0 cm and lymph node negative. The MammaPrint FFPE result is indicated for use by physicians as a prognostic marker only, along with other clinico-pathological factors.
The services discussed in this video are offered to educate consumers on healthcare and medical issues and should not substitute for medical advice, diagnosis or treatment. Talk to your health care provider for any questions regarding personal health or medical conditions.
Ещё видео!